[MALAKOF] QoQ Cumulative Quarter Result on 31-Mar-2020 [#1]

Stock
[MALAKOF] MALAKOFF CORPORATION BERHAD
Announcement Date
20-May-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2020
Quarter
31-Mar-2020 [#1]
Profit Trend
QoQ- -72.15%
YoY- 33.09%
Quarter Report
Latest QR
Upcoming QR
MALAKOF's Result
MALAKOF's Financial Summary
View:
Show?
Cumulative Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 6,276,763 4,763,037 3,280,142 1,773,973 7,422,272 5,681,171 3,822,135 38.98%
PBT 444,599 370,312 302,727 140,204 530,904 393,233 254,254 44.89%
Tax -114,530 -91,414 -84,417 -36,892 -156,218 -137,340 -110,380 2.47%
NP 330,069 278,898 218,310 103,312 374,686 255,893 143,874 73.50%
-
NP to SH 286,581 244,939 194,137 89,178 320,153 213,748 119,254 78.93%
-
Tax Rate 25.76% 24.69% 27.89% 26.31% 29.42% 34.93% 43.41% -
Total Cost 5,946,694 4,484,139 3,061,832 1,670,661 7,047,586 5,425,278 3,678,261 37.54%
-
Net Worth 5,326,830 5,375,700 5,375,700 5,375,700 5,473,440 5,522,309 5,474,000 -1.79%
Dividend
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Div 136,835 136,835 136,835 - 320,098 119,242 119,255 9.55%
Div Payout % 47.75% 55.87% 70.48% - 99.98% 55.79% 100.00% -
Equity
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Net Worth 5,326,830 5,375,700 5,375,700 5,375,700 5,473,440 5,522,309 5,474,000 -1.79%
NOSH 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 5,000,000 0.00%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin 5.26% 5.86% 6.66% 5.82% 5.05% 4.50% 3.76% -
ROE 5.38% 4.56% 3.61% 1.66% 5.85% 3.87% 2.18% -
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 128.44 97.46 67.12 36.30 151.88 116.25 78.20 38.99%
EPS 5.86 5.01 3.97 1.82 6.55 4.37 2.44 78.86%
DPS 2.80 2.80 2.80 0.00 6.55 2.44 2.44 9.56%
NAPS 1.09 1.10 1.10 1.10 1.12 1.13 1.12 -1.78%
Adjusted Per Share Value based on latest NOSH - 5,000,000
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
RPS 128.21 97.29 67.00 36.23 151.60 116.04 78.07 38.98%
EPS 5.85 5.00 3.97 1.82 6.54 4.37 2.44 78.65%
DPS 2.79 2.79 2.79 0.00 6.54 2.44 2.44 9.30%
NAPS 1.088 1.098 1.098 1.098 1.118 1.128 1.1181 -1.79%
Price Multiplier on Financial Quarter End Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 -
Price 0.895 0.945 0.91 0.805 0.87 0.86 0.855 -
P/RPS 0.70 0.97 1.36 2.22 0.57 0.74 1.09 -25.46%
P/EPS 15.26 18.85 22.91 44.11 13.28 19.66 35.04 -42.40%
EY 6.55 5.30 4.37 2.27 7.53 5.09 2.85 73.71%
DY 3.13 2.96 3.08 0.00 7.53 2.84 2.85 6.41%
P/NAPS 0.82 0.86 0.83 0.73 0.78 0.76 0.76 5.17%
Price Multiplier on Announcement Date
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Date 19/02/21 24/11/20 18/08/20 20/05/20 19/02/20 20/11/19 23/08/19 -
Price 0.835 0.93 0.955 0.825 0.895 0.885 0.88 -
P/RPS 0.65 0.95 1.42 2.27 0.59 0.76 1.13 -30.71%
P/EPS 14.24 18.56 24.04 45.21 13.66 20.23 36.07 -46.03%
EY 7.02 5.39 4.16 2.21 7.32 4.94 2.77 85.35%
DY 3.35 3.01 2.93 0.00 7.32 2.76 2.77 13.44%
P/NAPS 0.77 0.85 0.87 0.75 0.80 0.78 0.79 -1.68%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment